Who is sponsoring NCT03448965?

NCT03448965 is sponsored by Assiut University.

What drugs are being tested in NCT03448965?

Interventions in NCT03448965: random blood sugar.

What condition does NCT03448965 study?

NCT03448965 studies Hypoglycemia in Newborn Infants, Hyperglycemia.

Is NCT03448965 still recruiting?

NCT03448965 is currently status unknown. Last updated 28 February 2018.

Last reviewed 2018-02-28 · How we verify

NCT03448965

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hypoglycemic and Hyperglycemic Disorders

Status unknown Last updated 28 February 2018

What this trial tests

trial testing random blood sugar in Hypoglycemia in Newborn Infants in 100 participants. Status unknown.

Timeline

15 December 2018

Primary endpoint
20 October 2019

31 December 2019

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	15 December 2018
Primary completion	20 October 2019
Estimated completion	31 December 2019

Drugs / interventions tested

random blood sugar

Conditions studied

Hypoglycemia in Newborn Infants — all drugs for Hypoglycemia in Newborn Infants →
Hyperglycemia — all drugs for Hyperglycemia →

Sponsor

Assiut University

Who can join

Under 28 Days, any sex, with Hypoglycemia in Newborn Infants or Hyperglycemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Definition of low birth weight: Low birth weight infants are those born weighing less than 2500 g. These are further subdivided into: * Very Low Birth Weight : Birth weight \<1,500 g * Extremely Low Birth Weight : Birth weight \<1,000 g Their survival is directly related to birth weight, with approximately 20% of those between 500 and 600 g and\>90% of those between 1,250 and 1,500 g surviving. Perinatalcare has improved the rate of survival of low birth weight infants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03448965 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 28 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03448965.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing